Table 2.

Comparison of adjunctive treatments in the preoperative and postoperative periods

Intravitreal agent	Preoperative	Postoperative	p value
Anti-VEGF
Eyes, n (%)	33 (66%)	14 (28%)	<0.001*
IVI, n (mean±SD)	4.9±6	0.54±1.1	<0.001*
Median (range)	4 (0–30)	0 (0–5)
Dexamethasone
Eyes, n (%)	22 (44%)	14 (28%)	0.140
IVI, n (mean±SD)	1±1.7	0.8±1.7	0.495
Median (range)	0 (0–8)	0 (0–6)
Anti-VEGF and/or dexamethasone
Eyes, n (%)	40 (80%)	22 (44%)	<0.001*
IVI, n (mean±SD)	5.9±6.4	1.4±2.3	0.093
Median (range)	4 (0–30)	0 (0–11)

IVI, intravitreal injection; SD, standard deviation; VEGF, vascular endothelial growth factor.

*p value <0.05 comparing preoperative and postoperative values.